Denis Chem Lab Q1 FY27 results: PAT Rs 204.52 lakh, revenue Rs 4,399.67 lakh

EBITDA margin compressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.1%Reaction day

₹68.13

prior close

₹69.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+3.9% vs market

Pharmaceuticals peers, median of 166sector+0.1%+4.0% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+2.9

15m

+2.9

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.1+0.2+3.9+0.1+4.0

Next day

+4.1+0.2+3.8-0.3+4.3

+4.5+0.4+4.2-0.2+4.7

+5.1+0.7+4.4-0.4+5.5

+4.6+0.1+4.4-1.5+6.0

+4.2+0.7+3.5-0.9+5.1

+5.7+1.2+4.5-0.6+6.3

15d

+3.6+0.7+2.9+0.3+3.3

+3.3-1.2+4.5-0.2+3.4

-6.1-1.1-5.0-2.3-3.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Denis Chem Lab posted Q1 FY27 results with revenue from operations at Rs 4,399.67 lakh versus Rs 4,327.59 lakh in Q1 FY26, a rise of about 1.7 percent. Profit after tax stood at Rs 204.52 lakh versus Rs 247.50 lakh, down about 17.4 percent year-on-year. EPS was Rs 1.47 versus Rs 1.78. Auditor Shah and Shah Associates issued an unmodified limited review report. The company has zero debt and no defaults reported. It operates in a single segment of transfusion solutions.

Likely market impact

Mild revenue growth but PAT fell around 17 percent YoY as raw material costs and other expenses rose, squeezing margins. Business remains debt-free.